Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Silviu Itescu
|
| gptkbp:country |
gptkb:Australia
|
| gptkbp:developedBy |
MPC-06-ID
remestemcel-L rexlemestrocel-L |
| gptkbp:focusesOn |
regenerative medicine
stem cell therapy |
| gptkbp:foundedIn |
2004
|
| gptkbp:hasClinicalTrialsFor |
degenerative disc disease
chronic heart failure graft versus host disease COVID-19 related ARDS |
| gptkbp:headquartersLocation |
gptkb:Melbourne
|
| https://www.w3.org/2000/01/rdf-schema#label |
Mesoblast
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:NASDAQ
gptkb:ASX |
| gptkbp:notableProduct |
MPC-06-ID
remestemcel-L rexlemestrocel-L |
| gptkbp:specializesIn |
cell-based medicines
|
| gptkbp:stockSymbol |
gptkb:MSB
MESO |
| gptkbp:subsidiary |
Mesoblast, Inc.
|
| gptkbp:website |
https://www.mesoblast.com/
|
| gptkbp:bfsParent |
gptkb:Joseph_Swedish
|
| gptkbp:bfsLayer |
8
|